Disciplined Investments, LLC Myriad Genetics Inc Transaction History

Disciplined Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$17.56 - $23.76 $35 - $47	2 Added 22.22%	11 $0
Q1 2023 May 10, 2023	BUY	$15.26 - $23.75 $15 - $23	1 Added 12.5%	9 $0
Q4 2022 Feb 01, 2023	SELL	$14.51 - $20.99 $29 - $41	-2 Reduced 20.0%	8 $0
Q3 2022 Nov 03, 2022	BUY	$18.21 - $27.88 $127 - $195	7 Added 233.33%	10 $0
Q2 2022 Aug 09, 2022	SELL	$16.45 - $25.88 $49 - $77	-3 Reduced 50.0%	3 $0
Q1 2022 Apr 22, 2022	BUY	$22.67 - $28.01 $136 - $168	6 New	6 $0

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.